CSL names interim CEO Gordon Naylor its next chair

Reuters reports that Naylor has led the Australian biotechnology company on an interim basis since February 2026. He will replace retiring chair Brian McNamee on March 31, 2027; McNamee has held the role for more than eight years. The change comes days after CSL named Deborah Waterhouse its first female CEO.